'Total occlusion' presentation slideshows

Total occlusion - PowerPoint PPT Presentation

Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks

Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks

Management of Venous Occlusion: Tunneling, Venoplasty and Other Tricks. Seth J. Worley MD FHRS FACC The Heart Center Lancaster General Hospital. Disclosures. I receive compensation in various forms from St Jude, Medtronic, Boston Scientific, Pressure Products, Biosense and Oscor.

★ ★ ★ ★ ★

578 views • 42 slides
ANTIANGINAL DRUGS

ANTIANGINAL DRUGS

ANTIANGINAL DRUGS. ANTIANGINAL DRUGS. ILOs. By the end of those 2 lectures [24 slides for studing ] you will be able to: Recognize variables contributing to a balanced myocardial supply vs demand Identify etiopathogenic cascades contributing to ischemic heart disease

★ ★ ★ ★ ★

1.51k views • 41 slides
Prospective Analysis of Carotid Stenting in High Risk Patients

Prospective Analysis of Carotid Stenting in High Risk Patients

Prospective Analysis of Carotid Stenting in High Risk Patients. Dae Chul Suh, MD Asan Medical Center University of Ulsan College of Medicine. Acknowledgement. Neuoradiology Sang Joon Kim, MD Choong Gon Choi, MD Deok Hee Lee, MD Ho Sung Kim, MD Ha Young Lee, MD Jee Won Park, MD

★ ★ ★ ★ ★

572 views • 31 slides
Morbidity and Mortality

Morbidity and Mortality

Morbidity and Mortality. 1/30/02 G. Jeremy Juriansz. History of Present Illness: -81 y/o male presented to outside facility with a chief complaint of sudden onset of cough and SOB which awoke pt from sleep.

★ ★ ★ ★ ★

585 views • 30 slides
Disclosures

Disclosures

Characterization of Complex Coronary Artery Stenosis Morphology by Coronary Computed Tomographic Angiography. Brett M. Wertman, Victor Y. Cheng, Saibal Kar, Heidi Gransar, Ryan A. Berg, Hursh Naik, Rajendra Makkar, John D. Friedman, Jay N. Schapira, Daniel S. Berman

★ ★ ★ ★ ★

437 views • 30 slides
ANTIANGINAL DRUGS

ANTIANGINAL DRUGS

ANTIANGINAL DRUGS. ANTIANGINAL DRUGS. ILOs. By the end of those 2 lectures [24 slides for studing ] you will be able to: Recognize variables contributing to a balanced myocardial supply vs demand Identify etiopathogenic cascades contributing to ischemic heart disease

★ ★ ★ ★ ★

556 views • 26 slides
ANTIANGINAL DRUGS

ANTIANGINAL DRUGS

ANTIANGINAL DRUGS. ANTIANGINAL DRUGS. ILOs. By the end of those 2 lectures [24 slides for studing ] you will be able to: Recognize variables contributing to a balanced myocardial supply vs demand Identify etiopathogenic cascades contributing to ischemic heart disease

★ ★ ★ ★ ★

658 views • 24 slides
Complications of HSRA

Complications of HSRA

Complications of HSRA. Layth A. Mimish Consultant Cardiologist Cardiovascular Consultants Group Jeddah , Saudi Arabia. Slow/No Reflow. 1.8-17 % Long lesions Heavy calcification Small vessels Long rotablation time Intra luminal filling defects. Slow/No Reflow.

★ ★ ★ ★ ★

215 views • 9 slides
Occluded Artery Trial (OAT)

Occluded Artery Trial (OAT)

OAT Trial. Occluded Artery Trial (OAT). Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman. OAT Trial: Background.

★ ★ ★ ★ ★

107 views • 9 slides

View Total occlusion PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Total occlusion PowerPoint presentations. You can view or download Total occlusion presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.